Perspective
Ensuring Most-Favored Nation Drug Pricing Doesn’t Sicken Us
May 20, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Research
All Research Featured Research
Perspective
‘Most-Favored Nation’ Drug Pricing Has Three Significant Problems
April 14, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Journal Article
Care Continuity, Nephrologists’ Dialysis Facility Preferences, and Outcomes
April 11, 2025
Featured Experts: Eugene Lin, MD, MS, Khristina Ipapo Lung, MPH, Darius Lakdawalla, PhD, Desi Peneva, MS, Karen Van Nuys, PhD
White Paper
Lifetime Social Returns From Expanding Access to Anti-Obesity Medications
March 27, 2025
Featured Experts: Alison Sexton Ward, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH, Darius Lakdawalla, PhD, Dana Goldman, PhD
Journal Article
The Effect of US COVID-19 Excess Mortality on Social Security Outlays
February 18, 2025
Featured Experts: Hanke Heun-Johnson, PhD, Darius Lakdawalla, PhD, Bryan Tysinger, PhD
News
Analysis Finds Meaningful Impact on Pharmaceutical Innovation From Reduced Revenues
February 18, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD, Karen Van Nuys, PhD
White Paper
The Elasticity of Pharmaceutical Innovation: How Much Does Revenue Drive New Drug Development?
February 18, 2025
Featured Experts: Karen Van Nuys, PhD, Darius Lakdawalla, PhD, Dana Goldman, PhD
Perspective
Medicare Drug Price Negotiations Need Something New: A Floor
January 22, 2025
Featured Experts: Darius Lakdawalla, PhD
Comment Letter
Comments to Representatives DeGette and Bucshon on Building on the Successes of 21st Century Cures
August 8, 2024
Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD
Evidence Base
A Patient-Focused, Evidence-Driven Approach to PBM Reform
July 22, 2024
Featured Experts: Karen Van Nuys, PhD, Dana Goldman, PhD, Stephanie Hedt, MPP, Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Barry Liden, JD, Neeraj Sood, PhD, Erin Trish, PhD
Comment Letter
Comments to CMS on Transcatheter Tricuspid Valve Replacement (TTVR) and Broader CED Policy Considerations
July 18, 2024
Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD
Perspective
How To Advance The Debate Over QALYs: A Response To Kaplan et al.
June 10, 2024
Featured Experts: Jason Doctor, PhD, Darius Lakdawalla, PhD
Journal Article
A Roadmap for Improving Medicare’s Application of Coverage With Evidence Development
May 22, 2024
Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD
News
Schaeffer Center Researchers Make an Impact in Washington
April 25, 2024
Featured Experts: Darius Lakdawalla, PhD, Erin Trish, PhD, Karen Van Nuys, PhD, Neeraj Sood, PhD, Alice Chen, PhD
Issue Brief
A New Healthcare Valuation Model That Puts Patients First: Generalized Risk Adjusted Cost-Effectiveness (GRACE)
April 23, 2024
Featured Experts: Darius Lakdawalla, PhD, Stephanie Hedt, MPP, Barry Liden, JD
Journal Article
Risk Preferences Over Health: Empirical Estimates and Implications for Medical Decision-Making
March 1, 2024
Featured Experts: Karen Mulligan, PhD, Jason Doctor, PhD, Charles E. Phelps, PhD, Darius Lakdawalla, PhD
Journal Article
A Principled Approach to Non‑Discrimination in Cost‑Effectiveness
February 27, 2024
Featured Experts: Darius Lakdawalla, PhD, Jason Doctor, PhD
Testimony
Testimony on Ensuring Affordable and Valuable Pharmaceutical Innovation for Americans
February 8, 2024
Featured Experts: Darius Lakdawalla, PhD
Comment Letter
Response to Sen. Cassidy’s Request for Information on Improving Americans’ Access to Gene Therapies
January 19, 2024
Featured Experts: Darius Lakdawalla, PhD, Joseph Grogan, JD, Stephanie Hedt, MPP, Barry Liden, JD, Erin Trish, PhD, Karen Van Nuys, PhD